NIHR Brain Injury HTC becomes a MedTech Co-operative

We are delighted to announce that the NIHR Brain Injury Healthcare Technology Co-operative (www.brainhtc.org) has been awarded core funding of £1.25 million to continue its work to drive medtech innovation for patients after an acquired brain injury for a further 5 years (2018-2023) under the new banner of a Medtech Co-operative. The announcement by Health Secretary Jeremy Hunt of £14.25 million funding to support 11 NIHR MedTech and In vitro Diagnostic Co-operatives (MICs) coincides with the publication of Sir John Bell’s Life Sciences Industrial Strategy.

Dr Louise Wood, Director of Science, Research and Evidence at the Department of Health said:

“The funding received by the eleven NIHR MedTech and In-vitro diagnostic Co-operatives will make a real difference to patients’ lives and provide a focal point for the medtech and in-vitro diagnostic industries to develop new technologies and generate the evidence needed by the NHS to support the uptake of new tests.”

NIHR Brain Injury MedTech Co-operative team (Left to right): Dr Peter Jarritt (Deputy Director), Talissa Gasser (Communications & Project Officer), Professor John Pickard (Honorary Director), Mita Brahmbhatt (Programme Manager), Dr Alexis Joannides (Deputy Director).
NIHR Brain Injury MedTech Co-operative team (Left to right): Dr Peter Jarritt (Deputy Director), Talissa Gasser (Communications & Project Officer), Professor John Pickard (Honorary Director), Mita Brahmbhatt (Programme Manager), Dr Alexis Joannides (Deputy Director).

Based in Cambridge, the NIHR Brain Injury MedTech Co-operative has expertise in eleven clinical theme areas – with professional leadership as shown below – reflecting the patient pathway from initial ictus to final outcome and reintegration into the community.

  • Prevention and Pre- Hospital Care (Prof. Mark Wilson, Imperial College London),
  • Neurocritical Care (Prof. David Menon),
  • Multi-Modality Monitoring (Prof. Peter Hutchinson),
  • Intracranial Dynamics and Shunt Technology (Prof. Marek Czosnyka),
  • Functional Neuroimaging/Neurophysiology (Prof. Franklin Aigbirhio),
  • Neuro-oncology (Dr. Stephen Price),
  • Paediatrics and Neuro Development (Prof. David Rowitch and Dr. Topun Austin),
  • Regenerative Neuroscience (Dr. Mark Kotter),
  • Neurorehabilitation (Prof. Valerie Pomeroy, University of East Anglia),
  • Cognition and Mental Health (Prof. Barbara Sahakian),
  • and Neuropsychological Rehabilitation (Dr. Andrew Bateman, Oliver Zangwill Centre)

These themes are underpinned by four core support activities:

  • Patient and Public Involvement (Prof. Christi Deaton);
  • MedTech Regulation and Evaluation (Dr. Peter Jarritt);
  • Clinical Informatics and Registries (Dr. Alexis Joannides);
  • and Health Economics and Eco-system Modelling (Prof. Alonso Pena, University of Milan)

The MedTech Co-operative has a UK wide remit and will work with patients and public, NHS organisations and universities, including other MedTech and In vitro Diagnostic Co-operative (MICs), research councils, charities, industry, including  SMEs and start-ups to provide a structured and systematic approach to find areas of unmet need that might be amenable to a technology-based innovation,  facilitate the generation of innovative solutions and foster the translation of viable solutions from initial concept to successful market adoption and sustainable clinical  impact.

The National Institute for Health Research (NIHR): improving the health and wealth of the nation through research.

Established by the Department of Health, the NIHR:

  • funds high quality research to improve health
  • trains and supports health researchers
  • provides world-class research facilities
  • works with the life sciences industry and charities to benefit all
  • involves patients and the public at every step